Regulation of plasma long-chain fatty acid oxidation in relation to uptake in human skeletal muscle during exercise
Open Access
- 1 October 2004
- journal article
- clinical trial
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 287 (4), E696-E705
- https://doi.org/10.1152/ajpendo.00001.2004
Abstract
In the present study, we investigated possible sites of regulation of long-chain fatty acid (LCFA) oxidation in contracting human skeletal muscle. Leg plasma LCFA kinetics were determined in eight healthy men during bicycling (60 min, 65% peak oxygen uptake) with either high (H-FOX) or low (L-FOX) leg fat oxidation (H-FOX: 1,098 ± 140; L-FOX: 494 ± 84 μmol FA/min, P < 0.001), which was achieved by manipulating preexercise muscle glycogen (H-FOX: 197 ± 21; L-FOX: 504 ± 25 mmol/kg dry wt, P < 0.001). Several blood metabolites and hormones were kept nearly similar between trials by allocating a preexercise meal and infusing glucose intravenously during exercise. During exercise, leg plasma LCFA fractional extraction was identical between trials (H-FOX: 17.8 ± 1.6; L-FOX: 18.2 ± 1.8%, not significant), suggesting similar LCFA transport capacity in muscle. On the contrary, leg plasma LCFA oxidation was 99% higher in H-FOX than in L-FOX (421 ± 47 vs. 212 ± 37 μmol/min, P < 0.001). Probably due to the slightly higher ( P < 0.01) plasma LCFA concentration in H-FOX than in L-FOX, leg plasma LCFA uptake was nonsignificantly ( P = 0.17) higher (25%) in H-FOX than in L-FOX, yet the fraction of plasma LCFA uptake oxidized was 61% higher ( P < 0.05) in H-FOX than in L-FOX. Accordingly, the muscle content of several lipid-binding proteins did not differ significantly between trials, although fatty acid translocase/CD36 and caveolin-1 were elevated ( P < 0.05) by the high-intensity exercise and dietary manipulation allocated on the day before the experimental trial. The present data suggest that, in contracting human skeletal muscle with different fat oxidation rates achieved by manipulating preexercise glycogen content, transsarcolemmal transport is not limiting plasma LCFA oxidation. Rather, the latter seems to be limited by intracellular regulatory mechanisms.Keywords
This publication has 45 references indexed in Scilit:
- Different mechanisms can alter fatty acid transport when muscle contractile activity is chronically alteredAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Studies of plasma membrane fatty acid-binding protein and other lipid-binding proteins in human skeletal muscleProceedings Of The Nutrition Society, 2004
- Sarcolemmal FAT/CD36 in human skeletal muscle colocalizes with caveolin-3 and is more abundant in type 1 than in type 2 fibersJournal of Lipid Research, 2004
- Cloning and expression of the liver and muscle isoforms of ovine carnitine palmitoyltransferase 1: residues within the N-terminus of the muscle isoform influence the kinetic properties of the enzymeBiochemical Journal, 2003
- Whole body and leg acetate kinetics at rest, during exercise and recovery in humansThe Journal of Physiology, 2002
- The effects of increasing exercise intensity on muscle fuel utilisation in humansThe Journal of Physiology, 2001
- Identification of Caveolin-1 as a Fatty Acid Binding ProteinBiochemical and Biophysical Research Communications, 1999
- Membrane Associated Fatty Acid Binding Protein (FABPpm) in Human Skeletal Muscle Is Increased by Endurance TrainingBiochemical and Biophysical Research Communications, 1997
- The Mitochondrial Carnitine Palmitoyltransferase System — From Concept to Molecular AnalysisEuropean Journal of Biochemistry, 1997
- The membrane-associated 40 KD fatty acid binding protein (Berk's protein), a putative fatty acid transporter is present in human skeletal muscleLife Sciences, 1995